Design, synthesis, and biological evaluation of new thieno[2,3-d] pyrimidine derivatives as targeted therapy for PI3K with molecular modelling study
Elmenier, Fatma M; Lasheen, Deena; Abouzid, Khaled;
Abstract
Cancer is one of the most aggressive diseases characterised by abnormal growth and uncontrolled cell division. PI3K is a lipid kinase involved in cancer progression which makes it fruitful target for cancer control. 28 new morpholine based thieno[2,3-d] pyrimidine derivatives were designed and synthesised as anti-PI3K agents maintaining the common pharmacophoric features of several potent PI3K inhibitors. Their antiproliferative activity on NCI 60 cell lines as well as their enzymatic activity against PI3K isoforms were evaluated. Three compounds revealed good cytotoxic activities against breast cancer cell lines, especially T-47D. Compound VIb exhibited the best enzymatic inhibitory activity (72% & 84% on PI3Kβ & PI3Kγ), respectively and good activity on most NCI cell lines especially those with over expressed PI3K. Docking was carried out into PI3K active site which showed comparable binding mode to that of the PI-103 inhibitor. Compound VIb could be optimised to serve as a new chemical entity for discovering new anticancer agents.
Other data
Title | Design, synthesis, and biological evaluation of new thieno[2,3-d] pyrimidine derivatives as targeted therapy for PI3K with molecular modelling study | Authors | Elmenier, Fatma M; Lasheen, Deena ; Abouzid, Khaled | Keywords | PI3K and its isoforms;molecular docking;lipid kinase;cancer;Thieno[2,3-d] pyrimidine | Issue Date | Dec-2022 | Publisher | TAYLOR & FRANCIS LTD | Journal | Journal of Enzyme Inhibition and Medicinal Chemistry | ISSN | 1475-6366 | DOI | 10.1080/14756366.2021.2010729 | PubMed ID | 34955086 | Scopus ID | 2-s2.0-85121997345 | Web of science ID | WOS:000734650300001 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.